Lipitor Responsible for Type 2 Diabetes, Louisiana Woman Alleges in LawsuitOct 10, 2013
A woman claims that taking the cholesterol drug Lipitor for about a decade caused her to develop type 2 diabetes.
Law360.com reports that a Louisiana woman has filed a lawsuit against the drug maker Pfizer Inc., alleging that the company had repeatedly failed to warn the public about the risk of type 2 diabetes associated with Lipitor. Pfizer only agreed to put a warning on Lipitor labels in 2011, in a move prompted by the U.S. Food and Drug Administration (FDA).
The lawsuit claims she developed type 2 diabetes before the warning was applied to Lipitor and accuses Pfizer of failing to warn of the risk despite possessing evidence that clearly showed a link between the drug and diabetes.
Because that warning about Lipitor's link to higher blood glucose levels was not proclaimed until a couple of years ago, the Louisiana woman charges that she never monitored her blood sugar levels and didn't consider the possibility that Lipitor was affecting her metabolism in ways that resulted in her developing type 2 diabetes.
Based on our reports, type 2 diabetes is a growing public health epidemic associated with many adverse side effects, including increasing the risk of numerous fatal diseases, including heart disease.
The Louisiana woman says she began taking Lipitor in 1998 and continued to ingest it through 2009. She was diagnosed with type 2 diabetes in 2004 and continued to take Lipitor for five years after that diagnosis. She was originally prescribed Lipitor to reduce her cholesterol levels as a prevention measure against cardiovascular disease, according to her complaint, Law360.com notes.